# Study of Perifosine + Capecitabine for Colon Cancer Patients

> **NCT01048580** · PHASE1 · COMPLETED · sponsor: **AEterna Zentaris** · enrollment: 10 (actual)

## Conditions studied

- Colon Cancer

## Interventions

- **DRUG:** Perifosine
- **DRUG:** Capecitabine

## Key facts

- **NCT ID:** NCT01048580
- **Lead sponsor:** AEterna Zentaris
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10
- **Primary completion:** 2011-05
- **Final completion:** 2011-10
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2018-06-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01048580

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01048580, "Study of Perifosine + Capecitabine for Colon Cancer Patients". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01048580. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*